Add like
Add dislike
Add to saved papers

[Supplementation with high-dose L-carnitine on hemodialysis tolerance in uremic patients with severe heart diseases].

Objective: To investigate the effect of intravenous supplementation with high-dose L-carnitinen on hemodialysis tolerance in uremic patients with severe heart disease (ischemic heart disease, congestive heart disease and arrhythmia). Methods: Between March 2012 and March 2017, 5 gram L-carnitine was given after the completion of each hemodialysis treatment (3-4 times a week) over a period of two weeks in 29 maintenance hemodialysis patients with severe heart diseases manifested by frequently symptomatic hypotension, chest tightness, wheezing, palpitation, chest pain and other symptoms during hemodialysis. The hemodialysis duration, heart functional classification (New York Heart Association Functional Classification, NYHA ), blood pressure and arrhythmia were analyzed before and after the treatment. Results: The duration of hemodialysis was significantly prolonged after treatment [from 2.0-3.5 (2.6±0.4)h to 3.0-4.0 (3.8±0.4) h, t =10.66, P <0.01]. Cardiac function was improved ( Z =-4.74, P <0.01). The hypotension and arrhythmia during dialysis was improved. Conclusion: High-dose of intravenous L-carnitine supplementation can improve hemodialysis tolerance and the symptoms of heart failure, arrhythmia, ischemic cardiac disease in hemodialysis patients with severe heart diseases.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app